2 minute read

Epstein-Barr Virus

Disease Transmission And Prevention



Spread of the virus from one person to another requires close contact. Because of viral proliferation and replication in the lining of the mouth, infectious mononucleosis is often dubbed "the kissing disease." Also, because it inhabits cervical cells, researchers now suspect EBV may be sexually transmitted. Rarely is EBV transmitted via blood transfusion.



EBV is one of the latent viruses, which means it may be present in the body, lying dormant often for many years and manifesting no symptoms of disease. The percentage of shedding (transmission) of the virus from the mouth is highest in people with active IM or who have become immunocompromised for other reasons. A person with active IM can prevent transmission of the disease by avoiding direct contact—such as kissing—with uninfected people. However, shedding has been found to occur in 15% of adults who test positive for antibodies but who show no other signs of infection, thus allowing the virus to be transmitted. Research efforts are directed at finding a suitable vaccine.

The prevalence of antibodies against EBV in the general population is high in developing countries and lower socioeconomic groups where individuals become exposed to the virus at a very young age. In developed countries, such as the United States, only 50% of the population shows traces of antibody by the age of five years, with an additional 12% in college-aged adolescents, half of whom will actually develop IM. This situation indicates that children and adolescents between the age of 10 to 20 years are highly susceptible to IM in developed countries, making it a significant health problem among young students and those in the military.


Resources

Books

Bell, David S. The Doctor's Guide to Chronic Fatigue Syndrome: Understanding, Treating, and Living with CFIDS. Reading, MA: Addison-Wesley, 1993.

Flint, S.J., et al. Principles of Virology: Molecular Biology, Pathogenesis, and Control Washington: American Society for Microbiology, 1999.

Richman, D.D., and R.J. Whitley. Clinical Virology. 2nd ed. Washington: American Society for Microbiology, 2002.

Periodicals

Liebowitz, David. "Epstein-Barr Virus—An Old Dog With New Tricks." The New England Journal of Medicine 332, no. 1 (5 January 1995): 55-57.


Marie L. Thompson

KEY TERMS

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Antibody

—A molecule created by the immune system in response to the presence of an antigen (a foreign substance or particle). It marks foreign microorganisms in the body for destruction by other immune cells.

Arthralgia

—Joint pain without inflammation.

B cell

—Immune system white blood cell that produces antibodies.

Immunosuppressed/immunocompromised

—Reduced ability of the immune system to fight disease and infection.

Myalgia

—Muscular aches and pain.

Nasopharyngeal

—Of the nose and throat.

T cells

—Immune-system white blood cells that enable antibody production, suppress antibody production, or kill other cells.

Additional topics

Science EncyclopediaScience & Philosophy: Ephemeris to Evolution - Historical BackgroundEpstein-Barr Virus - Discovery, Disease, And Research, Origin And Development, Disease Transmission And Prevention